Excellent
Mostly Aligned
Patient Risk:
Low
Summary
All evaluated claims (brand-name identity and drug class) are directly consistent with the provided labeling for DEMADEX (torsemide). The third claim is not addressed in the provided label excerpts, so it cannot be confirmed or contradicted based on the supplied prescribing information.
Category Scores
Accurate Statements
Demadex is the brand name for torsemide.
Provided labeling identifies the product as DEMADEX (torsemide) tablets with active ingredient torsemide.
Demadex is a loop diuretic.
Provided labeling mechanism of action describes torsemide inhibiting the Na+/K+/2Cl- carrier system in the thick ascending portion of the loop of Henle, consistent with a loop diuretic.
Unsupported Statements
Generic torsemide is usually the main lower-cost option when insurance or cash prices make the brand expensive.
The provided FDA-approved prescribing information excerpts do not mention pricing, cost, insurance, or comparative affordability. Therefore this claim is not supported or contradicted by the supplied label text.
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The only unsupported content is about cost/market behavior rather than dosing, contraindications, warnings, or safety monitoring.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Mostly Aligned
Primary Issue
Pricing/cost assertion is not supported by the provided prescribing information excerpts.
Suggested Improvement
Remove or qualify the cost/affordability claim, or base it on non-label sources. Limit label-derived statements to identity/class/indications/dosing/safety content.